Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 15.6B | 15.7B | 13.3B | 14.7B |
Cost of revenue | 13.2B | 11.8B | 10.5B | 7.4B |
Gross profit | 2.4B | 3.9B | 2.8B | 7.3B |
Operating expense | ||||
Research & development | 584.9M | 572.2M | 499.8M | 647.1M |
Selling general and admin | 343.1M | 234.7M | 168.4M | 173.9M |
Other operating expenses | 176.7M | 190.5M | 143.2M | 282.9M |
Operating income | 907.6M | 2.3B | 1.5B | 5.1B |
Non operating interest income | ||||
Income | 46.0M | 71.3M | 110.0M | 76.0M |
Expense | 358.7M | 233.9M | 148.1M | 104.6M |
Other income expense | — | — | — | — |
Pretax income | 260.7M | 2.0B | 1.4B | 4.9B |
Tax provision | -3.3M | 250.1M | 111.1M | 690.3M |
Net income | 264.0M | 1.7B | 1.3B | 4.2B |
Basic EPS | 0.1 | 0.7 | 0.5 | 1.6 |
Diluted EPS | 0.1 | 0.6 | 0.5 | 1.6 |
Basic average shares | 2.7B | 2.7B | 2.7B | 2.6B |
Diluted average shares | 2.7B | 2.7B | 2.7B | 2.6B |
EBITDA | 2.5B | 3.6B | 2.7B | 6.1B |
Net income from continuing op. | 264.0M | 1.7B | 1.3B | 4.2B |
Minority interests | 118.6M | 29.0M | -7.4M | 14.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |